ANAPTYSBIO, INC. (ANAB) Net margin 2017–2026
ANAPTYSBIO, INC. (ANAB) net profit margin by fiscal year — reported net income divided by reported revenue.
-5.6%FY2026 · since FY2017: -25.5% → -5.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -5.6% | +153.5 pp |
| FY2025 | -159.1% | +794.6 pp |
| FY2024 | -953.7% | +297.7 pp |
| FY2023 | -1251.3% | -1159.8 pp |
| FY2022 | -91.5% | -64.9 pp |
| FY2021 | -26.6% | +1190.1 pp |
| FY2020 | -1216.7% | +16.4 pp |
| FY2019 | -1233.1% | -932.4 pp |
| FY2018 | -300.7% | -275.2 pp |
| FY2017 | -25.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ANAB financial trends
ANAB RevenueANAB Net incomeANAB Gross profitANAB Gross marginANAB Operating incomeANAB Operating marginANAB Operating cash flowANAB Free cash flowANAB Capital expendituresANAB Return on equityANAB Stock buybacksANAB Dividends paidANAB Total assetsANAB Total liabilitiesANAB Shareholders’ equityANAB overview →